|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses | ||||
| General and administrative (Note 18) | ||||
| Research and development, net (Note 19) | ||||
| Total operating expenses | ||||
| Changes in fair value of derivative warrants liabilities (Note 7) | ||||
| Unrealized loss on short-term investment (Note 5) | ||||
| Finance income (expenses) | ||||
| Changes in fair value of derivative warrant liabilities (Note 7) | ||||
| Changes in fair value of short-term investments (Note 5) | ||||
| Interest expense | ||||
| Foreign exchange gain (loss) | ||||
| Other finance expenses | ||||
| Interest income on deposit | ||||
| Changes in fair value of convertible loans | ||||
| Total finance income (expenses) | ||||
| Other income | ||||
| Dividend received | ||||
| Total other income | ||||
| Loss Before taxes | ||||
| Tax expenses | ||||
| Net Loss | ||||
| Net Loss | ||||
| Loss per share, basic (in Dollars per share) | ||||
| Loss per share, diluted (in Dollars per share) | ||||
| Weighted average number of shares for the purposes of basic loss per share (in Shares) | ||||
| Weighted average number of shares for the purposes of diluted loss per share (in Shares) | ||||
Loading...